Amneal’s Generics Business Reinvigorated By New Launches

Company Eyes China As A ‘Massive Market’ For Its Generics

As Amneal’s generics segment sees significant growth, the company has revealed plans to launch new products and expand in new markets. “We are extremely proud of the progress our company has made since we re-joined as leaders of Amneal,” said Chirag and Chintu Patel, co-CEOs of Amneal.

ladder
Amneal made 29 new ANDA filings in 2020 and expects to file 30 products in 2021 • Source: Shutterstock

More from Strategy

More from Business